Investing now, at scale and as a collective global effort is vital to change the course of the pandemic.
At least $8 billion of new funding is needed for the global response to COVID-19 – for research, development and supply of treatments for all, and support for public health measures in countries with the weakest health systems.
Research is the best way to save lives, bring the COVID-19 pandemic to an end and prevent it reappearing.
We're also calling on researchers, journals and funders to share their research data and findings rapidly and openly.
All R&D funders, developers, manufacturers and governments must help to make sure that new vaccines, tests and treatments developed for COVID-19 are globally available, appropriate and affordable for everyone, regardless of where they have been developed or who has funded them.
Science will show us the way out of the COVID-19 pandemic. And businesses and philanthropy can play a major role by stepping up to fund coronavirus treatments, as well as vaccines and tests.
With measures to prevent the spread of COVID-19 disrupting immunisation around the globe, millions are now at risk of other deadly diseases. We must act and invest urgently to maintain routine immunisation.
During the COVID-19 pandemic, researchers and publishers have pulled together to publish their outputs at an unprecedented rate. How will this change research culture and the way findings are disseminated in future?
[Summary] Our polling of more than 6,000 adults in the UK, the USA, Germany and France shows strong public support for making sure that any new coronavirus treatments and vaccines are first made available to those who need them most.